| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/10/2001 | US6258351 Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/10/2001 | CA2139653C Optically pure salts of pyridinylmethyl sulfinyl-ih- benzimidazole compounds |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047960A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047901A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047538A1 Genus leontopodium plant extract and compositions containing same |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047530A1 A method of therapy and prophylaxis of inflammation |
| 07/05/2001 | WO2001047526A1 Remedies for external use for allergic skin diseases |
| 07/05/2001 | WO2001047525A1 Antipruritic agents for external use |
| 07/05/2001 | WO2001047507A2 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | WO2000076464A3 Oxidatively stable, long-chain ethyl ester emollients |
| 07/05/2001 | WO2000073278A3 5-phenyl-pyrimidine derivatives |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000061621A3 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 07/05/2001 | WO2000055137A8 Compounds and methods for modulation of estrogen receptors |
| 07/05/2001 | US20010007020 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/05/2001 | US20010007019 Useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing |
| 07/05/2001 | US20010006966 Use of 1- (aminoalkyl) -3-quinoxaline-2-on derivatives for the preparation of compounds having an antioxidant action |
| 07/05/2001 | US20010006957 Microdispersed or microfibrillar polyanhydroglucuronic acids and salts, complex salts or intermolecular polymer complexes suitable for fixing drug dosages with significantly protracted effect and reduced toxicity |
| 07/05/2001 | US20010006813 Cultivation of eucaryotic cells |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |
| 07/05/2001 | US20010006625 Comprising one or more glucocorticoids, physiologicall tolerable solvent(s), and water insoluble film-forming agents |
| 07/05/2001 | CA2699568A1 Azaindoles |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2395663A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395575A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395284A1 Inhibition of gsk-3.beta. |
| 07/05/2001 | CA2395236A1 Basolateral sorting signal and inhibitors thereof |
| 07/05/2001 | CA2395173A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394393A1 Remedies for external use for allergic skin diseases |
| 07/05/2001 | CA2393583A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | CA2393529A1 Inhibitors of complement activation, their preparation and use |
| 07/04/2001 | EP1112745A1 Homeopathic composition |
| 07/04/2001 | EP1112744A1 Zinc oxide as plasminogen activator inhibitor for external use |
| 07/04/2001 | EP1112741A1 Use of protease inhibitors for the treatment of necrotizing infections |
| 07/04/2001 | EP1112738A2 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 07/04/2001 | EP1112361A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 07/04/2001 | EP1112285A1 Human chordin-related proteins and polynucleotides encoding them |
| 07/04/2001 | EP1112262A1 SUBSTITUTED $g(g)-PHENYL-$g(D)-LACTONES AND ANALOGS THEREOF AND USES RELATED THERETO |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112087A2 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
| 07/04/2001 | EP1112079A1 Myrtle extract, preparation method and use |
| 07/04/2001 | EP1112076A1 Polymeric compounds and methods of formulating same |
| 07/04/2001 | EP1112072A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1112057A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution) |
| 07/04/2001 | EP1112053A1 Organosilicone compositions for personal care |
| 07/04/2001 | EP0814776B1 Topically applied pharmaceutical composition, method of preparing it and its use |
| 07/04/2001 | EP0706370B1 Stable topical retinoid compositions |
| 07/04/2001 | CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302215A Local preparation containing poloxamer and other microbe killing agent and applicator |
| 07/04/2001 | CN1301543A Skin external use agent |
| 07/04/2001 | CN1301538A Melanin cell growth promotor for external use for skin and producing method thereof |
| 07/04/2001 | CN1301537A Liniment for skin disease and use |
| 07/04/2001 | CN1301534A Stable slow-releasing oral administration composition |
| 07/04/2001 | CN1067976C Asiatic acid derivatives its manufacturing method and dermatological agent containing it |
| 07/04/2001 | CN1067902C Decrustation ointment for burn and its preparing process |
| 07/04/2001 | CN1067897C Medicine for cleaning scar and stain on skin |
| 07/04/2001 | CN1067895C Chinese and western medicinal preparation for curing hand and foot tinea and preparing method thereof |
| 07/04/2001 | CN1067889C Traditional Chinese Medicine compound disinfactant |
| 07/04/2001 | CN1067886C Preparation of scald ointment |
| 07/04/2001 | CN1067885C Burn curing powder |
| 07/04/2001 | CN1067879C Preparation for curing dermatomycosis |
| 07/03/2001 | USRE37263 Topically applying two solutions, gels or creams one of a metal chlorite and thickener and one of a protic acid and thickener |
| 07/03/2001 | US6255495 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups and method of application thereof |
| 07/03/2001 | US6255453 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 07/03/2001 | US6255353 Inhibition of angiogenesis |
| 07/03/2001 | US6255324 Amino-and mercurio-substituted 4′,5'-dihydropsoralens and therapeutical uses thereof |
| 07/03/2001 | US6255290 Reducing sensitivity to skin cancer; topical administering of nucleotide |
| 07/03/2001 | US6255281 Complexing uteroglobin to fibronectin |
| 07/03/2001 | US6255279 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 07/03/2001 | US6254853 Drugs with carriers |
| 07/03/2001 | CA2291144C Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 06/30/2001 | CA2293852A1 Procedure for preparing active plant extracts used to trap free radicals; the extracts and compounds and devices containing them |
| 06/29/2001 | CA2293913A1 Treatment of necrotizing infections |
| 06/28/2001 | WO2001046443A2 Proteases |
| 06/28/2001 | WO2001046392A2 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | WO2001046327A2 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane |